Related Experiment Video
Updated: Mar 20, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
DNA methylation and Cancer: Identifying and targeting epigenetic modifications may be the future of cancer therapy?
1University of Malta Medical School, Mater Dei Hospital Msida, Malta, Europe.
Abstract:
DNA methylation has been recognized as one of the most important epigenetic mechanisms regulating the expression and inhibition of genes giving rise to an organism's phenotype. It is hence of no surprise that when DNA methylation mechanisms are disrupted by intrinsic or extrinsic causes, the likelihood of tumourigenesis increases. Both hypermethylation and hypomethylation may predispose to cancer formation through aberrant inhibition or expression of particular genes and this is seen in different types of cancers, such as laryngeal squamous cell carcinoma and acute myeloid leukaemia. By increasing our knowledge and understanding of these epigenetic mechanisms, we will be able to develop diagnostic techniques such as methylation profiling, to screen for and detect aberrant methylation patterns which may predispose to cancer formation in our patients. This would enable early diagnosis and treatment which may also involve the use of drugs developed to provide directed epigenetic therapy, shifting away from the current trend which involves the use of radical anti-cancer therapy. These diagnostic and treatment options may be the future of cancer management.
Insights
DNA methylation, an epigenetic mechanism, influences gene expression and phenotype. Aberrant DNA methylation (hypermethylation and hypomethylation) is linked to cancer development, necessitating new diagnostic and therapeutic strategies.
Area of Science:
- Epigenetics
- Molecular Biology
- Oncology
Background:
- DNA methylation is a key epigenetic mechanism regulating gene expression and phenotype.
- Disruptions in DNA methylation, through hypermethylation or hypomethylation, are linked to increased cancer risk.
- Aberrant methylation patterns are observed in various cancers, including laryngeal squamous cell carcinoma and acute myeloid leukemia.
Purpose of the Study:
- To explore the role of DNA methylation in tumorigenesis.
- To highlight the potential of understanding epigenetic mechanisms for cancer management.
- To introduce methylation profiling as a diagnostic tool.
Main Methods:
- Review of existing literature on DNA methylation and cancer.
- Analysis of aberrant methylation patterns in different cancer types.
- Discussion of potential diagnostic and therapeutic applications.
Main Results:
- DNA methylation alterations (hyper- and hypomethylation) are implicated in cancer development.
- Specific methylation patterns are associated with distinct cancer types.
- Methylation profiling offers a method for early cancer detection.
Conclusions:
- Understanding DNA methylation is crucial for advancing cancer diagnostics and therapeutics.
- Methylation profiling can aid in early cancer detection and risk assessment.
- Epigenetic therapies targeting DNA methylation represent a promising future direction in cancer management.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Cancer
Mitogens and the Cell Cycle

